American Diversified Holdings Corporation

American Diversified Holdings Corporation

ADHC
American Diversified Holdings CorporationUS flagOther OTC
0.00
USD
- -
- -
443,059.00Market Cap
American Diversified Holdings Corporation
ADHC
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
American Diversified Holdings Corporation American Diversified Holdings Corporation (ADHC) operates as a holding company focused on artificial intelligence-based technology development in the healthcare sector, providing executive management, corporate governance, administrative support, financial advisory services, and introductions to capital sources primarily to micro-cap public companies; it also develops medical AI applications and operates e-commerce platforms in the wellness industry, including sites such as universalwellnessshop. The company, founded in 2001 and headquartered at 122 15th Street, Del Mar, California, maintains a small team of approximately three employees and targets the health care technology segment with an emphasis on mobile healthcare platforms tailored for patient monitoring, ailment-specific protocols, bio device technologies, and innovative wellness solutions. In recent developments, American Diversified Holdings Corporation completed the acquisition of GlucoGuard, an AI-driven medical device technology from IMD Solutions in Phoenix, Arizona, enhancing its portfolio in non-invasive glucose monitoring and medical diagnostics as announced in October 2025; it continues to advance AI-focused medical technologies while shifting from traditional consulting services toward integrated healthcare innovation through strategic technology acquisitions.

Company News

APIChat
  • American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA

  • American Diversified Holdings Corporation (ADHC) Announces Internal Technology Initiative Within Universal Wellness AI Division

  • GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program

  • American Diversified Holdings Corporation Receives $5,000,000 (Five Million) Financing Commitment from an Institutional Investment Fund

  • Metavesco: ADHC Joins OTCfi Movement With Treasury Purchase

  • American Diversified Holdings Corporation (ADHC) Provides Udpate on Arete Bioscience GlucoGuard Design Project

  • GlucoGuard Receives $43 Million Enterprise Valuation Research Report

  • Harbinger Research Publishes Coverage Initiation Report, on American Diversified Holdings Corporation (ADHC) and Its Operating Division, GlucoGuard

  • GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program

  • American Diverisfied Holdings Corporation (ADHC) to Retain San Diego Based Bio Device Engineering Firm, Arete Bioscience, to Design GlucoGuard's Oral Diabetes Management Device

  • American Diversified Holdings Corporation (ADHC) Receives Favorable FDA Review

  • GlucoGuard Files Breakthrough Device Application with US Food and Drug Administration

  • American Diversified Holdings Corporation Forms Strategic Alliance with Tech Kahunas LLC a Leading Technology, Cyber-Security and Software Development Firm

  • American Diversifield Holdings Corporation (ADHC) Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program

  • American Diversified Holdings Corporation (ADHC) Retains Dr. Stephen C. Weber, MD, FACS As Head of Medical Advisory Board

  • Glucoguard, a Division of ADHC, Completes AI Based Mobile Application and Design Outline (MADO) for Dexcom API Integration

  • American Diversified Holdings Corporation (ADHC) Completes Acquisition Of GlucoGuard, a AI-Based Medical Device for Managing Nocturnal Hypoglycemia in Diabetic Patients

  • American Diversified Holdings Corporation (ADHC) to Acquire GlucoGuard, a AI-Based Medical Device for Managing Nocturnal Hypoglycemia in Diabetic Patients

  • American Diversified Holdings Corporation Announces the Cancellation of 466 Million Shares

  • American Diversified Holdings Corporation Announces a Major Debt Restructuring Eliminating $2.727 Million in Debt from Their Balance Sheet